Concepedia

Lucia Lione

LL

Statistics

Publications

7

Citations

240

H-Index

7

Active since

2019

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

NeuroMetrix (United States)

RINA Consulting - Centro Sviluppo Materiali S.p.A. (Italy)

AlmavivA (Italy)

Takasago (United States)

Lucia Lione is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in immunology, cancer immunology, and vaccinology.

ORCID

Publications per year

2019–2023

7

Publications

7

COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models

Antonella Conforti, Emanuele Marra, Fabio Palombo et al. · Molecular Therapy · 2021 · 69 citations · Full text

, , +17

Neoantigen cancer vaccine augments anti-CTLA-4 efficacy

Erika Salvatori, Lucia Lione, Mirco Compagnone et al. · npj Vaccines · 2022 · 48 citations · Full text

, , +17

Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth

Luigi Aurisicchio, Erika Salvatori, Lucia Lione et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 44 citations · Full text

, , +17

A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19

Luigi Aurisicchio, Nadia Brambilla, Marina Elena Cazzaniga et al. · Molecular Therapy · 2022 · 28 citations · Full text

, , +17

Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition

Lucia Lione, Erika Salvatori, Adriana Petrazzuolo et al. · OncoImmunology · 2021 · 24 citations · Full text

, , +17

1–5 of 7